News Home » Medical and Pharma » Roche drug cocktail doubles chance of holding lung cancer at bay

Around the World

Roche drug cocktail doubles chance of holding lung cancer at bay

James Bay 2 December 7, 2017
Adding Roche's (ROG.S) immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease advancing, an outcome some experts labeled…